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Abstract
Background: Coreopsis tinctoria is a traditional remedy for the management of various diseases including hepatitis.
The hepatoprotective role of the plant is not scientifically explored till now. This study was designed to investigate
the hepatoprotective potentials of the ethanol extract from C. tinctoria (CTEtOH) using an animal model of carbon
tetrachloride (CCl4)-induced acute liver injury.
Methods: CTEtOH (0.5 and 1.0 g/kg) and silymarin (200 mg/kg) were administered to the experimental mice for
7 days followed by 0.2% CCl4 (10 mL/kg of body weight (bw), ip), then all mice were sacrificed after 24 h. The
serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were measured. Histological
analysis of liver was performed. The tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), nitric
oxide (NO), malondialdehyde (MDA), and antioxidant enzymatic activities were also measured..
Results: The results revealed that the serum ALT and AST levels significantly decreased after treatment with CTEtOH.
Moreover, histological analyses indicated that CTEtOH (0.5 and 1.0 g/kg) and silymarin reduced the extent of CCl4-
induced liver lesions. CTEtOH (0.5 and 1.0 g/kg) reduced the levels of malondialdehyde, nitric oxide, and
proinflammatory cytokines (TNF-α and IL-1β). Furthermore, CTEtOH (1.0 g/kg) reduced the level of IL-6. The activities of
antioxidant enzymes, namely superoxide dismutase and glutathione reductase, significantly increased after treatment
with CTEtOH (0.5 and 1.0 g/kg) and that of glutathione peroxidase increased after treatment with 1.0 g/kg of CTEtOH.
Conclusions: These results demonstrate the hepatoprotective effect of CTEtOH against CCl4-induced acute liver injury
in mice, and the underlying hepatoprotective mechanisms are associated with antioxidant and antiproinflammatory
activities.
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Background
Coreopsis tinctoria Nutt. (Asteraceae) is a small, glab-
rous, aromatic annual plant commonly used for folk me-
dicinal purposes worldwide. In North American Indians,
C. tinctoria is used to treat several disorders such as
diarrhea, internal pain, and bleeding [1]. In addition, it
has been used as a traditional remedy for diarrhea, liver
diseases, and diabetes for a long period. Flower infusion
tea is used as a beverage to treat hypertension and
hyperlipidemia [2]. Pharmacological studies have indi-
cated that C. tinctoria exhibits some biological effects in-
cluding antioxidant [3], antidiabetic [4], antihypertensive
[5], and cytoprotective [1] activities. Although C. tinc-
toria is used for liver diseases, studies have yet to report
on its hepatoprotective effect. In addition, studies have
identified rich flavonoids, such as chalcones, flavanones,
and flavonols. Among these compounds, marein (oka-
nin-4′-O-d-glucopyranoside) has been identified as a
major flavonoid [2, 5].
* Correspondence: chunpin@hsc.edu.tw; whpeng@mail.cmu.edu.tw
†Equal contributors
2Hsin Sheng College of Medical Care and Management, Taoyuan, Taiwan,
Republic of China
3Department of Chinese Pharmaceutical Sciences and Chinese Medicine
Resources, College of Pharmacy, China Medical University, Taichung 404,
Taiwan, Republic of China
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Tsai et al. BMC Complementary and Alternative Medicine  (2017) 17:139 
DOI 10.1186/s12906-017-1604-8
The liver plays a vital role in metabolism and has some
physiological functions [6]. Liver detoxification occurs in
two phases, namely phase I (involving oxidation, reduc-
tion, and hydrolysis) and phase II (involving synthetic
conjugations with sulfates, glucuronic acid, glutathione,
acetate, and glycine), and these phases convert toxic ma-
terials into harmless metabolites and then excrete them
from the body [7]. Liver diseases are considered serious
problems which can be caused by toxic chemicals, drugs,
and virus infiltration through ingestion or infection [8].
These toxins induce the production of reactive oxygen
species (ROS), which can attack hepatic tissue and cause
serious injury [9, 10].
Carbon tetrachloride (CCl4) is a potent toxin, and ani-
mal models involving CCl4-induced hepatic injury have
been widely used to evaluate the potential of medicine
or food to protect against hepatotoxicity [11]. The cyto-
chrome P450 system metabolizes CCl4 to the highly re-
active trichloromethyl radical CCl3 , which can react
with oxygen to form the trichloromethyl peroxyl radical
CCl3OO and then attack lipids or proteins. This reac-
tion can initiate lipid peroxidation and cause damage to
liver tissue [12]. Antioxidants may protect against oxida-
tive stress-related liver pathologies such as CCl4-induced
liver lesions by blocking the chain of lipid peroxidation
[13]. In recent years, antioxidant activities of herbs have
been comprehensively investigated and some herbs or
derived chemical components are good sources [14].
This study investigated the hepatoprotective effect of
the ethanol extract of C. tinctoria flowers (CTEtOH) on
CCl4-induced acute liver damage in mice. Serum alanine
aminotransferase (ALT) and aspartate aminotransferase
(AST) levels were estimated to evaluate liver function. In
addition, pathological biopsies were examined. The levels
of proinflammatory cytokines such as TNF-α, IL-1β, and
IL-6; nitric oxide (NO); malondialdehyde (MDA); and
antioxidant enzymes such as superoxide dismutase (SOD),
glutathione peroxidase (GPx), and glutathione reductase
(GRd) were measured to elucidate the underlying mech-
anism. Silymarin, a group of flavones extracted from Sily-
bum marianum L., is a strong antioxidant and an effective
protective agent against CCl4-induced liver injury and
hepatic fibrosis. In this study, silymarin was used as a posi-
tive control. The total polyphenol and total flavonoid con-
tents were also determined.
Methods
Preparation of plant extract
C. tinctoria flowers were obtained and identified by Dr.
Xiu-Ying Hao, Institute of Microbiology, Xinjiang Acad-
emy of Agricultural Sciences (Urumqi, Xinjiang, China).
The plant specimen (voucher specimen number:
CPSCMR-103-012) was deposited in the Department of
Chinese Pharmaceutical Sciences and Chinese Medicine
Resources, College of Pharmacy, China Medical Univer-
sity (Taichung, Taiwan). Dried flowers (3.0 kg) were
soaked in 1 L of 70% ethanol at 45 °C four times and
then filtered. The filtrates were concentrated under re-
duced pressure using a vacuum rotary evaporator. Sub-
sequently, the remaining solution was lyophilized to
obtain the crude extract (CTEtOH, 694.3 g). The extract
was stored at −20 °C until further use.
Materials
CCl4 was purchased from Merck Co. (Germany) and dis-
solved in olive oil (0.2%, v/v). AST, ALT, SOD, GPx, and
GRd assay kits were purchased from Randox Laboratory
Ltd (UK). TNF-α, IL-1β, and IL-6 were purchased from
eBioscience Inc. (USA). Folin-Ciocalteu’s phenol reagent,
sodium carbonate (Na2CO3), aluminum chloride (AlCl3),
thiobarbituric acid, Griess reagent, catechin, rutin, and
silymarin (≥90%) were purchased from Sigma-Aldrich
Chemical Co. (USA). All other reagents used were of
analytical grades.
Animals
ICR mice (20–25 g) were obtained from BioLasco
Taiwan Co., Ltd (Taipei, Taiwan). The mice were housed
under normal laboratory conditions (21 ± 2 °C and 12/
12-h light-dark cycle) with free access to standard pellet
diet and water. All animal procedures were conducted in
accordance with the standards set forth in the guidelines
for the Care and Use of Experimental Animals by the
Committee for the Purpose of Control and Supervision
of Experiments on Animals and the National Institutes
of Health. The study protocol was approved by the Ani-
mal Ethics Committee of China Medical University
(Number: 103–314).
CCl4-induced hepatotoxicity
The animals were randomly divided into six groups, with
10 mice in each group. Distilled water was administered
to Group 1 (control) and Group 2 (CCl4) and silymarin
(200 mg/kg) was administered to Group 3 orally. CTE-
tOH was administered to Groups 4, 5, and 6 at doses of
0.1, 0.5, and 1.0 g/kg (in 0.5% carboxymethylcellulose),
respectively. After administration for 7 consecutive days,
CCl4 (10 mL/kg BW, 0.2% in olive oil) was injected in-
traperitoneally 1 h after the last administration except
for the control group. The mice in the control group
were injected an equivalent volume of olive oil intraperi-
toneally. At 24 h after CCl4 injection, all the mice were
sacrificed under anesthesia. Their livers were rinsed in
four times volume of Tris-HCl buffer, then homogenized
and centrifuged at 12,000 rpm for 10 min at 4 °C to sep-
arate the supernatant. The supernatant was used for
histological analyses and TNF-α, IL-1β, IL-6, NO, MDA,
and antioxidant enzymatic activity measurements.
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Serum biochemical analysis
Blood was collected and centrifuged at 3000 rpm (Beckman
GS-6R, Germany) at 4 °C for 30 min to separate the serum.
Serum ALT and AST levels were measured using spectro-
photometric diagnostic kits (Roche, Germany).
Histological analysis
Liver samples were fixed in a 10% buffered formaldehyde
solution and processed using the paraffin slice tech-
nique. For hematoxylin and eosin staining, sections were
stained with hematoxylin for 4 min, washed, and then
stained with 0.5% eosin for an additional 4 min. The de-
gree of liver damage was examined under a light micro-
scope by a pathologist (Dr. Liao; Graduate Institute of
Veterinary Pathobiology, Taichung, Taiwan, R.O.C.) who
was blinded to the study purpose.
MDA assay
MDA is the end product of lipid peroxidation. In this
study, MDA was measured using the thiobarbituric acid-
reactive substances (TBARS) assay [15]. One milliliter of
the supernatant was mixed with 1 mL of TBA solution
and boiled for 45 min to form red TBARS (under the
acidic condition). The absorbance was measured at
532 nm. MDA levels are expressed in nanomoles per
milligram of protein (nmole/mg protein).
NO assay
NO levels were measured using the NO assay kit
(ab65327) [16]. This kit provides an accurate and con-
venient measure of the total nitrate or nitrite concentra-
tion in a simple two-step process. In the first step,
nitrate is converted to nitrite by nitrate reductase. In the
second step, nitrite reacts with the fluorescent probe 2,
3-diaminonaphthalene, and the corresponding fluores-
cence is measured at Ex/Em = 360/450 nm. NaOH en-
hances the fluorescence yield. The fluorescence intensity
is proportional to the total NO production. The kit has
been tested with culture media, plasma, and tissue ho-
mogenates. The results are expressed as the sum of ni-
trite and nitrate concentrations.
TNF-α, IL-1ß, and IL-6 assays
TNF-α, IL-1β, and IL-6 were measured using enzyme-
linked immunosorbent assays. A capture antibody was
added to each well and incubated overnight. On the fol-
lowing day, a biotinylated antibody was added and incu-
bated with sample tissues or standard antigens. Finally,
streptavidin was added to end the reaction, and the ab-
sorbance was recorded at 450 nm. The results are
expressed in picograms per milligram of protein (pg/mg)
for cytokine concentrations.
Antioxidant enzymatic activity measurements
Liver homogenates were prepared in cold Tris-HCl buf-
fer by using a homogenizer, to evaluate SOD, GPx, and
GRd activities. These antioxidant enzymatic activities
were determined using the kits purchased by Randox
Laboratories Ltd. by following the manufacturer’s in-
structions and detected using the Chem Well®-T Auto-
mated Chemistry Analyzer. The results are expressed in
units per milligram of protein (U/mg protein).
Determination of total polyphenol and total flavonoid
content
The total polyphenol content was evaluated using the
Folin-Ciocalteu method [17]. The sample (20 μL,
250 μg/mL) was added to 40 μL of Folin-Ciocalteu re-
agent and 200 μL of distilled water in each well. The
mixture was shaken and maintained at room
temperature for 5 min before the addition of 40 μL of
20% Na2CO3. The solution was mixed, and the absorb-
ance was measured at 680 nm. The assay was conducted
in triplicates. (+)-Catechin was used for the calibration
curve, and the results are expressed in micrograms of
(+)-catechin equivalents per milligram of the dry weight
extract.
The total flavonoid content was determined as follows.
First, 100 μL of the sample extract was mixed with an
equal volume of AlCl3 · 6H2O solution (2%). The mixture
was shaken and maintained at room temperature for
10 min. Subsequently, the absorbance was measured at
430 nm [18]. The assay was conducted in triplicates.
Rutin was used for the calibration curve, and the results
are expressed in micrograms of rutin equivalents per
milligram of the dry weight extract.
HPLC analysis
The HPLC fringerprint was established according to pre-
vious study [2] and by a Shimazu HPLC system compris-
ing of a LC-10 AD VP Pumps, a SPD-10AV VP
Detector, aSIL-10 AD VP AutoSampler and a DGU -
14A Degasser. Separations were carried out with a
Thermo Scientific Hypersil ODS C18 column (4.6 mm ×
250 mm, 5 μm, USA). The injection volume was 10 μl
and each sample was filtered through a 0.45 μm Mini-
pore filter. The mobile phase consisted of acetonitrile
(A) and 0.05% formic acid (B) using a gradient elution of
5–20% A at 0–60 min and 20–40% A at 60–110 min.
The flow rate was 1.0 ml/min and the detection wave-
length was 254 nm.
Statistical analysis
All data are presented as the mean ± SEM. Statistical
analyses were performed using SPSS software and
one-way ANOVA followed by Scheffe’s multiple range
tests. Histological analyses were conducted using the
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nonparametric Kruskal-Wallis test followed by the
Mann-Whitney U test. The criterion for statistical sig-
nificance was p < 0.05.
Results
Effect of CTEtOH on CCl4-induced hepatotoxicity
Figure 1 presents the hepatoprotective effect of CTEtOH
on CCl4-induced liver injury. Serum ALT and AST levels
increased in the CCl4 group significantly. However, these
increased serum ALT and AST levels decreased after
treatment with CTEtOH (0.5 and 1.0 g/kg) and silymarin
(200 mg/kg). These results indicate that CTEtOH has
protective functions against CCl4-induced liver damage.
Histological analyses
As illustrated in Fig. 2, CCl4-induced injury included in-
creased vacuole formation, neutrophil infiltration, and
necrosis. However, the damage decreased after pretreat-
ment with CTEtOH (0.5 and 1.0 g/kg) and silymarin
(200 mg/kg).
Effect of CTEtOH on the MDA and NO levels
The MDA level was determined to evaluate the degree of
hepatic lipid peroxidation. The results revealed that the
MDA level significantly increased in the CCl4 group
(Fig. 3a). However, the MDA level decreased in the CTE-
tOH (0.5 and 1.0 g/kg) and silymarin (200 mg/kg) groups.
As presented in Fig. 3b, the NO level considerably in-
creased in the CCl4 group. However, compared with the
CCl4 group, the NO level significantly decreased in the
CTEtOH (0.5 and 1.0 g/kg) and silymarin groups.
Effect of CTEtOH on TNF-α, IL-1β, and IL-6 levels in the
liver
Table 1 presents the levels of proinflammatory cytokines,
namely TNF-α, IL-1β, and IL-6, in CCl4-induced acute
liver injury. The levels of these cytokines in the CCl4
group were remarkably higher than those in the control
group. Treatment with silymarin (200 mg/kg) or CTE-
tOH (0.5 and 1.0 g/kg) significantly reduced the levels of
TNF-α and IL-1β. Similarly, treatment with silymarin
(200 mg/kg) or CTEtOH (1.0 g/kg) significantly reduced
the levels of IL-6.
Effects of CTEtOH on antioxidant enzymatic activities
The activities of SOD, GPx, and GRd were measured to
evaluate the antioxidant effects of CTEtOH. Compared
with the control group, the activities of these antioxidant
enzymes significantly decreased in the CCl4 group
(Table 2). Furthermore, the activities of SOD and GRd
significantly increased after treatment with CTEtOH at
doses of 0.5 and 1.0 g/kg. The activity of GPx signifi-
cantly increased after treatment with 1.0 g/kg of
CTEtOH.
Total polyphenol and flavonoid contents
The total polyphenol content was measured using the
Folin-Ciocalteu method and is expressed in milligram
Fig. 1 Effects of CTEtOH and silymarin on serum AST and ALT levels in mice treated with CCl4. Each value is represented as the mean ± SEM
(n = 10). ### p < 0.001, compared with the control group. *p < 0.05 and **p < 0.01, compared with the CCl4 group (one-way ANOVA followed by
Scheffe’s multiple range test)
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gallic acid equivalents per gram of the dry weight extract
(mg GAE/g). The results revealed that the total polyphe-
nol content of CTEtOH was 248.14 ± 6.51 mg GAE/g.
The total flavonoid content is expressed in milligram
rutin equivalents per gram of the dry weight extract (mg
RE/g) and the content of CTEtOH was 123.41 ± 4.53 mg
QE/g.
HPLC analysis
The HPLC fingerprint of CTEtOH is shown in Fig. 4. In
the chromatogram, peaks at the retention time of
22.55 min and 50.71 min were detected, representing
chlorogenic acid and marein respectively.
Discussion
Animal models of CCl4-induced liver injury are com-
monly used to investigate the hepatoprotective effects of
natural medicine. An increase in serum AST and ALT
levels has been attributed to the damaged hepatic struc-
ture. Liver injury can be evaluated by determining serum
AST and ALT levels [19]. The results of the present
study reveal that treatment with CTEtOH significantly
reduced AST and ALT levels. In addition, histological
analyses indicate that hepatic cell injury was accompan-
ied by vacuole formation, neutrophil infiltration, and ne-
crosis around the central vein after CCl4 administration.
The observed liver damage was significantly improved
after treatment with CTEtOH. These results indicate the
hepatoprotective effect of CTEtOH on CCl4-induced
hepatotoxicity.
Inflammation is initiated by CCl4-induced hepatotox-
icity, followed by the release of proinflammatory media-
tors including inducible NO synthase (iNOS), TNF-α,
IL-1β, and IL-6. NO is a crucial proinflammatory medi-
ator and a highly active nitrogen species produced by
iNOS during the conversion of l-arginine to l-citrulline
[20]. Moreover, NO reacts with superoxide anions to
form a strong cytotoxic oxidant, namely peroxynitrite,
which causes lipid peroxidation and cellular damage
[21]. The overproduction of NO can cause hepatic in-
jury, and the inhibition of NO can reduce inflammatory
damage. TNF-α, IL-1β, and IL-6 are critical cytokines in
Fig. 2 Hepatic histological analyses of CTEtOH and silymarin on CCl4-induced acute liver damage in mice. Liver tissues were subjected to
hematoxylin and eosin staining (400×). a Control group; (b) animals treated with 0.2% CCl4; displayed cell necrosis (long arrow) and vacuole
formation (short arrow) (c) animals pretreated with silymarin (200 mg/kg) and then treated with CCl4; (d–f) animals pretreated with CTEtOH (0.1,
0.5, and 1.0 g/kg) and then treated with CCl4
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inflammatory responses, and their levels are increased
during the development of liver damage [13]. TNF-α,
which is produced by Kupffer cells, can induce immune
responses by activating T cells and macrophages and fur-
ther stimulate the secretion of other inflammatory cyto-
kines and the production of NO [22]. IL-1β is another
proinflammatory cytokine playing a vital role in the
regulation of hepatic NO synthesis [23]. IL-6 stimulates
hepatocytes to produce various acute-phase proteins and
protects against liver injury [24]. Our results reveal that
the production of NO, TNF-α, IL-1β, and IL-6 signifi-
cantly decreased after treatment with CTEtOH, thus
demonstrating that CTEtOH exerts a hepatoprotective
effect on CCl4-induced injury.
Lipid peroxidation is one of the major characteristics
of CCl4-induced hepatotoxicity [25]. MDA, the end
product of lipid peroxidation, is formed by free radicals
attacking the plasma membrane and is widely used as a
marker of lipid peroxidation injury [26]. In the current
study, an increase in the hepatic MDA level suggested
the enhancement of lipid peroxidation, consequently
leading to hepatic damage as well as the inactivation of
the antioxidant defense system. However, the increased
hepatic MDA level decreased after treatment with CTE-
tOH. ROS formed in the CCl4-induced liver damage
model could significantly reduce the expressions of anti-
oxidant enzymes such as SOD, GPx, and GRd [19].
Therefore, an increase in antioxidant activity and the in-
hibition of free radical generation are positively corre-
lated with hepatic protection. SOD dissimulates
superoxide to H2O2 in the enzymatic defense against
oxygen toxicity. Both GPx and GRd are GSH-related en-
zymes and play detoxifying and antioxidant roles in cel-
lular defense through conjugation with glutathione or
the reduction of free radicals. GPx works with GSH to
metabolize H2O2, a harmful toxin, to nontoxic products,
and GRd catalyzes the reduction of GSSG to GSH [27].
Our results reveal that the activities of SOD, GPx, and
GRd significantly decreased during the development of
CCl4-induced acute liver injury; this finding is in agree-
ment with those of previous studies [11, 28]. In this
Fig. 3 Effects of CTEtOH and silymarin on the liver MDA (a) and NO
(b) levels in mice treated with CCl4. Each value is represented as the
mean ± SEM (n = 10). ### p < 0.001, compared with the control
group. *p < 0.05, **p < 0.01, and ***p < 0.001, compared with the
CCl4 group (one-way ANOVA followed by Scheffe’s multiple
range test)
Table 1 Effect of CTEtOH on the levels of different proinflammatory cytokines in CCl4-treated mice
Groups Pro-inflammatory cytokines (pg/mg protein)
TNF-α IL-1β IL-6
Control 31.88 ± 2.17 161.86 ± 13.66 8.70 ± 0.51
CCl4 82.74 ± 5.02
### 1608.68 ± 33.86### 33.89 ± 1.76###
CCl4 + Silymarin (200 mg/kg) 51.24 ± 2.04
*** 994.86 ± 35.66*** 15.97 ± 1.60***
CCl4 + CTEtOH (0.1 g/kg) 87.54 ± 4.53 1445.95 ± 88.75 36.05 ± 5.77
CCl4 + CTEtOH (0.5 g/kg) 66.02 ± 6.78
* 1275.45 ± 151.73* 28.28 ± 2.28
CCl4 + CTEtOH (1.0 g/kg) 60.82 ± 4.76
* 1168.69 ± 97.21** 23.23 ± 1.30*
Each value is represented as the mean ± S.E.M. (n = 10). ###p < 0.001, compared with the control group. *p < 0.05, **p < 0.01, and ***p < 0.001, compared with the
CCl4 group (one-way ANOVA followed by Scheffe’s multiple range test)
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study, the activities of SOD, GPx, and GRd improved
after treatment with CTEtOH. These findings suggest
that CTEtOH reduces ROS production by increasing
hepatic antioxidant activities and protecting against hep-
atotoxicity. The suppression of MDA production is likely
to promote the activities of SOD, GPx, and GRd. Fur-
thermore, an increase in SOD activity not only increases
the superoxide anion scavenging capacity but also pre-
vents the peroxynitrite production.
Phenolic compounds, such as flavonoids and phenolic
acids, that are present in many plant species were re-
ported to express high antioxidant activity in stabilizing
lipid oxidation [29]. These phenolic compounds possess
antioxidant properties and protect hepatocytes against
chemically induced liver carcinogenesis. The mecha-
nisms underlying this chemoprevention include stimula-
tion of the induction of apoptosis in transformed
hepatocytes and inhibition or scavenging of ROS, which
eliminates or lowers the extent of lipid peroxidation or
inflammation in liver cells, ultimately preventing the in-
cidence of hepatic necrosis [30]. In addition, the antioxi-
dant properties of some of these plants, especially of
their isolated compounds, have therapeutic benefits in
pathological conditions such as liver diseases, cancer,
diabetes, and heart diseases. However, a considerable
percentage of these potential antioxidant plants, particu-
larly those with promising hepatoprotective properties,
is yet to be explored. C. tinctoria contains various types
of bioactive chemical compounds, such as flavonoids,
phenols, phenylpropanoids, polyacetylene glycosides,
and sterols, and flavonoids are major phytochemical
compounds [5]. Some chemical compositions of C. tinc-
toria have been separated and identified, including mar-
ein, okanin, coreopsin, taxifolin, and isookanin [2, 5]. In







Control 5.33 ± 0.12 0.856 ± 0.088 0.104 ± 0.012
CCl4 4.68 ± 0.11
## 0.391 ± 0.061### 0.051 ± 0.007##
CCl4 + Silymarin (200 mg/kg) 6.06 ± 0.14
*** 0.812 ± 0.120** 0.092 ± 0.008**
CCl4 + CTEtOH (0.1 g/kg) 4.74 ± 0.18 0.436 ± 0.068 0.056 ± 0.040
CCl4 + CTEtOH (0.5 g/kg) 5.93 ± 0.08
*** 0.567 ± 0.052 0.801 ± 0.006*
CCl4 + CTEtOH (1.0 g/kg) 5.92 ± 0.07
*** 0.771 ± 0.091** 0.891 ± 0.011**
Each value is represented as the mean ± S.E.M. (n = 10). ##p < 0.01 and ### p < 0.001, compared with the control group. *p < 0.05, **p < 0.01, and ***p < 0.001,
compared with the CCl4 group (one-way ANOVA followed by Scheffe’s multiple range test)
Fig. 4 HPLC chromatogram at 254 nm. Key to the peaks: 1-chlorogenic acid, 2-marein
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the present study, the results indicated that C. tinctoria
contains high contents of total polyphenols and total fla-
vonoids. The HPLC fingerprint also indicated that C.
tinctoria have chlorogenic acid, which displays good he-
patoprotective effect [31]. However, additional studies
should be conducted to determine the principal active
compounds and their mechanisms underlying the hepa-
toprotective effect.
Conclusions
In conclusion, this is the first study to demonstrate that
CTEtOH expressed hepatoprotective activity against
CCl4-induced acute hepatotoxicity in mice. The results
indicate that CTEtOH not only enhances hepatic anti-
oxidant enzyme activities and inhibits lipid peroxidation
but also suppresses inflammatory responses in CCl4-in-
duced liver damage. The possible hepatoprotective
mechanism correlates with the inhibition of lipid peroxi-
dation through increasing the activities of antioxidant
enzymes and the regulation of proinflammatory media-
tors to maintain the integrity of hepatic cells. Because C.
tinctoria is demonstrated in this study to exhibit a hepa-
toprotective effect against chemically induced liver in-
jury, it can be potentially developed into a functional
food or even a pharmacological agent for the prevention
of liver diseases.
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